MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.

Employees

Sector

Drug Retailers

More about the company

Real-time Euronext Paris 15:30:11 23/10/2019 BST			5-day change	1st Jan Change
20.20 ^EUR	-.--%		-.--%	+18.82%

09/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
17/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI

Market Cap	38.47M 34.44M 32.1M 29.12M 54.92M 3.68B 55.26M 386M 151M 1.9B 145M 141M 6.11B	P/E 2017	17.4x	P/E 2018	19.8x
Enterprise Value	36.72M 32.87M 30.64M 27.79M 52.42M 3.51B 52.75M 368M 144M 1.81B 138M 135M 5.83B	EV / Sales 2017	1.97x	EV / Sales 2018	1.38x
Free-Float	5.42%	Yield 2017	3.36%	Yield 2018	-

09/12/21	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
17/09/20	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI
17/09/19	Curae Lab SARL agreed to acquire remaining 12.5% stake in Millet Innovation SA from Holding Managers for €4.8 million.	CI

25/10/19	Millet Innovation : MILLET INNOVATION - MISE EN OEUVRE DU RETRAIT OBLIGATOIRE
09/10/19	Millet Innovation : Communiqué de mise à disposition des Autres informations
08/10/19	Millet Innovation : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE D’INFORMATION ETABLI PAR CURAE LAB
18/09/19	Millet Innovation : DEPOT PROJET DE NOTE D’INFORMATION EN REPONSE RELATIVE A L’OPAS
17/09/19	Millet Innovation : RAPPORT SEMESTRIEL AU 30/06/2019

Millet Innovation Share Price

Stocks

ALINN

FR0010304402

Drug Retailers

Valuation: Millet Innovation

Latest news: Millet Innovation

News in other languages: Millet Innovation

Managers and Directors: Millet Innovation

Retail - Drugs without Grocery

Financials

Company Profile

Manager	Title	Age	Since
Damien Millet CEO	Chief Executive Officer	-	08/12/2002
Valérie Chopinet DFI	Director of Finance/CFO	-	18/12/2006

Director	Title	Age	Since
Jean-Claude Millet CHM	Chairman	-	15/03/1998
Pierre Martin BRD	Director/Board Member	-	15/03/1998
Jean-Paul Maingaud BRD	Director/Board Member	-	30/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MILLET INNOVATION	-.--%	-.--%	-	-	42.79M
JD HEALTH INTERNATIONAL INC.	-0.06%	+4.10%	-42.40%	-9.74%	14.66B
RAIA DROGASIL S.A.	+3.07%	+10.05%	+17.24%	-21.91%	7.53B
MATSUKIYOCOCOKARA & CO.	+0.65%	+1.87%	-14.91%	-7.25%	6.15B
TSURUHA HOLDINGS INC.	-0.40%	+3.03%	-12.83%	-1.00%	6.08B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-0.35%	+1.24%	-54.18%	-42.77%	5.89B
YIFENG PHARMACY CHAIN CO., LTD.	+3.91%	+7.21%	+1.96%	-13.13%	4.35B
COSMOS PHARMACEUTICAL CORPORATION	+0.52%	+3.13%	-24.91%	-18.29%	3.2B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+2.35%	+5.49%	+14.83%	-21.41%	3.19B
NAHDI MEDICAL COMPANY	-2.29%	-1.43%	-26.03%	-34.58%	3.17B
Average	+0.74%	+4.10%	-15.69%	-18.90%	5.43B
Weighted average by Cap.	+0.75%	+4.62%	-20.05%	-16.67%

	2017	2018
Net sales	21.86M 19.57M 18.24M 16.55M 31.21M 2.09B 31.4M 219M 85.82M 1.08B 82.11M 80.29M 3.47B	22.21M 19.88M 18.53M 16.81M 31.71M 2.12B 31.91M 223M 87.19M 1.1B 83.43M 81.58M 3.53B
Net income	2.54M 2.28M 2.12M 1.92M 3.63M 243M 3.65M 25.5M 9.98M 125M 9.55M 9.34M 404M	1.63M 1.46M 1.36M 1.24M 2.33M 156M 2.35M 16.37M 6.41M 80.53M 6.13M 6M 259M
Net Debt	-1.07M -954K -889K -807K -1.52M -102M -1.53M -10.69M -4.18M -52.57M -4M -3.91M -169M	-1.75M -1.57M -1.46M -1.33M -2.5M -168M -2.52M -17.57M -6.88M -86.44M -6.58M -6.44M -278M